My Account

  • Home
  • KLOW 8Omg
KLOW 8Omg
KLOW 8Omg - Image 2

KLOW 8Omg

  • This product is sold strictly for laboratory research purposes only.
  • It is not approved for human or veterinary use and is not intended to diagnose, treat, cure, or prevent any disease.
  • By purchasing this product, you acknowledge and agree that it will be used solely for legitimate laboratory research.

$ 135

Out of stock

The Klow Blend combines four research peptides, BPC-157, TB-500, KPV, and GHK-Cu, formulated for studies on cellular repair, immune modulation, and extracellular matrix regulation. BPC-157 is a 15 amino acid gastric peptide fragment that modulates nitric oxide and growth factor pathways. TB-500, a segment of Thymosin Beta-4, regulates actin polymerization and tissue remodeling. KPV, derived from the C-terminal region of alpha-melanocyte-stimulating hormone, modulates NF-κB and cytokine signaling. GHK-Cu, a copper(II)-complexed tripeptide, influences metalloprotein activity and redox balance. Together, these peptides are used in research examining regeneration, inflammation, and peptide–metal interaction mechanisms.

Description

The BPC-157 + TB-500 (Thymosin Beta-4) + KPV + GHK-Cu Blend is a multi-peptide research formulation designed to support investigation into synergistic mechanisms of tissue repair, inflammation regulation, and regenerative biology. Each peptide included in this blend has independently demonstrated robust activity in preclinical models of wound healing, immune modulation, angiogenesis, and protection against tissue degeneration. While BPC-157, TB-500, GHK-Cu, and KPV share overlapping biological themes—namely cytoprotection, inflammation control, and regenerative signaling—they act through distinct molecular pathways. Combining these peptides into a single formulation enables researchers to study how complementary mechanisms converge to influence healing kinetics, tissue quality, and long-term functional outcomes. This blend was developed to simplify experimental design by reducing the logistical complexity associated with administering multiple peptides independently. By consolidating these peptides into one formulation, researchers may focus on mechanistic interrogation, biomarker analysis, and outcome measurement rather than protocol complexity.

Related Products

KPV 1Omg

Selank 1Omg

Thymosin Alpha-1 1Omg

PT-141 1Omg

Tesamorelin 1Omg

BPC-157 10mg